M A Kotowicz

Author PubWeight™ 42.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992 4.19
2 Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 2001 2.08
3 Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med 1996 2.00
4 An unusual case of Marine-Lenhart syndrome. Thyroid 2003 1.97
5 Age- and gender-specific rate of fractures in Australia: a population-based study. Osteoporos Int 1999 1.69
6 The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res 1998 1.65
7 Health burden of hip and other fractures in Australia beyond 2000. Projections based on the Geelong Osteoporosis Study. Med J Aust 1999 1.62
8 The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int 2006 1.52
9 Oral contraceptives and bone mineral density: A population-based study. Am J Obstet Gynecol 2000 1.42
10 Fracture rates lower in rural than urban communities: the Geelong Osteoporosis Study. J Epidemiol Community Health 2002 1.34
11 Identification of incident fractures: the Geelong Osteoporosis Study. Aust N Z J Med 1999 1.29
12 Femoral neck geometry and hip fracture risk: the Geelong osteoporosis study. Osteoporos Int 2005 1.15
13 Prevalence of osteoporosis in Australian women: Geelong Osteoporosis Study. J Clin Densitom 2000 1.13
14 Vitamin D status of women in the Geelong Osteoporosis Study: association with diet and casual exposure to sunlight. Med J Aust 2001 1.04
15 Bone mineral density reference ranges for Australian men: Geelong Osteoporosis Study. Osteoporos Int 2009 1.02
16 Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women. Osteoporos Int 2001 0.99
17 Calcium intakes among Australian women: Geelong Osteoporosis Study. Aust N Z J Med 2000 0.93
18 The Taq IA and Ser311 Cys polymorphisms in the dopamine D2 receptor gene and obesity. Diabetes Nutr Metab 2003 0.91
19 Reference ranges for bone densitometers adopted Australia-wide: Geelong osteoporosis study. Australas Radiol 2004 0.90
20 Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality of life in men. Osteoporos Int 2008 0.90
21 Dietary omega-3 fatty acids and depression in a community sample. Nutr Neurosci 2004 0.89
22 Overreporting of vitamin D deficiency with the Roche Elecsys Vitamin D3 (25-OH) method. Pathology 2011 0.88
23 Lower levels of physical activity in childhood associated with adult depression. J Sci Med Sport 2010 0.86
24 Patterns of treatment in Australian men following fracture. Osteoporos Int 2010 0.85
25 Fracture risk among older men: osteopenia and osteoporosis defined using cut-points derived from female versus male reference data. Osteoporos Int 2013 0.84
26 Assessment of fracture risk: value of random population-based samples--the Geelong Osteoporosis Study. J Clin Densitom 2001 0.83
27 Bone mineral density is cross sectionally associated with cartilage volume in healthy, asymptomatic adult females: Geelong Osteoporosis Study. Bone 2011 0.82
28 Associations between measures of adiposity over 10 years and patella cartilage in population-based asymptomatic women. Int J Obes (Lond) 2013 0.82
29 Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. J Clin Endocrinol Metab 2001 0.81
30 Incident hip fracture and social disadvantage in an Australian population aged 50 years or greater. Bone 2010 0.80
31 A comparison of diabetes clinics with different emphasis on routine care, complications assessment and shared care. Diabet Med 2008 0.80
32 Age-related reference intervals for bone turnover markers from an Australian reference population. Bone 2013 0.80
33 The social gradient of fractures at any skeletal site in men and women: data from the Geelong Osteoporosis Study Fracture Grid. Osteoporos Int 2015 0.80
34 Factors influencing reticulophagocytic function in insulin-treated diabetes. Diabetes 1984 0.79
35 Prior fracture as a risk factor for future fracture in an Australian cohort. Osteoporos Int 2014 0.78
36 Relationship of serum leptin to total and truncal body fat. Clin Sci (Lond) 1997 0.77
37 Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability. Diabet Med 1998 0.76
38 Is there an interaction between socioeconomic status and FRAX 10-year fracture probability determined with and without bone density measures? Data from the Geelong Osteoporosis Study of female cohort. Calcif Tissue Int 2015 0.76
39 Femoral neck dimensions are unlikely to be associated with age at menarche. Osteoporos Int 1999 0.75
40 Calcaneal ultrasound reference ranges for Australian men and women: the Geelong Osteoporosis Study. Osteoporos Int 2012 0.75
41 Examining the impact of reimbursement on referral to bone density testing for older adults: 8 years of data from the Barwon Statistical Division, Australia. Arch Osteoporos 2013 0.75
42 Fracture thresholds revisited. Geelong Osteoporosis Study. J Clin Epidemiol 2002 0.75
43 Metabolic profiles in diabetic subjects treated with human insulin (Novo) and porcine insulin. Diabetes Care 1983 0.75